Liver cancer is the third leading cause of cancer death worldwide. Representing such a
dramatic impact on our lives, liver cancer is a significant public health concern. Sustainable …

Besides smoking, lung cancer can be caused by other factors, including heavy metals such
as cadmium, nickel, arsenic, beryllium and hexavalent chromium [Cr (VI)], which is used in …

Chimeric antigen receptor (CAR) therapy is a promising immunotherapeutic strategy for
treating multiple refractory blood cancers, but further advances are required for solid tumor …

Background Hepatocellular carcinoma (HCC) is a common primary malignant tumor which
usually progresses to an advanced stage because of late diagnosis. Sorafenib (Sora) is a …

A lack of relevant genetic models and cell lines hampers our understanding of
hepatoblastoma pathogenesis and the development of new therapies for this neoplasm …

Although oxaliplatin-based chemotherapy has been effective in the treatment of
hepatocellular carcinoma (HCC), primary or acquired resistance to oxaliplatin remains a …

Purpose: The majority of tumor-specific antigens are intracellular and/or secreted and
therefore inaccessible by conventional chimeric antigen receptor (CAR) T-cell therapy …

Background & Aims Hepatoblastoma (HB) is the most common childhood liver cancer and
occasionally presents with histological and clinical features reminiscent of hepatocellular …

Endoplasmic reticulum stress (ERS) can be induced by a variety of physiological and
pathological factors including oxidative stress, which triggers the unfolded protein response …

Background & Aims Large extracellular vesicles, specifically AnnexinV+ EpCAM+ CD147+
tumour-associated microparticles (taMPs), facilitate the detection of colorectal carcinoma …